Heterobivalent fibroblast activation protein-targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention.

lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42727450

Baocheng Chen; Hongxin Li; Kongzhen Hu; Mingming Sun; Ningjie Li; Qianyong Cao; Ruitao Yang; Zexin Xu

Sep 12, 2026